1999
DOI: 10.1006/abio.1999.4128
|View full text |Cite
|
Sign up to set email alerts
|

A Homogeneous and Multiplexed Immunoassay for High-Throughput Screening Using Fluorometric Microvolume Assay Technology

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

1
74
0

Year Published

2000
2000
2021
2021

Publication Types

Select...
6
3

Relationship

0
9

Authors

Journals

citations
Cited by 113 publications
(75 citation statements)
references
References 10 publications
1
74
0
Order By: Relevance
“…Recently, several multiplex protein analysis technologies have been developed, including slide/microarray-based assays (Knight et al, 2004;Tam et al, 2002;Wiese et al, 2001) and flow cytometry-based assays (Fulton et al, 1997;Oliver et al, 1998;Swartzman et al, 1999;Cook et al, 2001). Flow cytometry-based systems are currently the most widely used multiplex biomarker analysis technology.…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…Recently, several multiplex protein analysis technologies have been developed, including slide/microarray-based assays (Knight et al, 2004;Tam et al, 2002;Wiese et al, 2001) and flow cytometry-based assays (Fulton et al, 1997;Oliver et al, 1998;Swartzman et al, 1999;Cook et al, 2001). Flow cytometry-based systems are currently the most widely used multiplex biomarker analysis technology.…”
Section: Introductionmentioning
confidence: 99%
“…Flow cytometry-based systems are currently the most widely used multiplex biomarker analysis technology. The Luminex-100 system uses uniformly sized microspheres internally labeled with graded proportions of a red and a near infrared fluorophore, 658 and 712 nm, providing the capacity to interrogate and classify 100 discrete beads (Fulton et al, 1997;Oliver et al, 1998;Swartzman et al, 1999;Martins, 2002). This is in contrast to the BD CBA system that discriminates beads based upon fluorescence intensity from a single fluorophore, which limits the multiplexing capacity (Cook et al, 2001).…”
Section: Introductionmentioning
confidence: 99%
“…Labeled probe methods such as multilabel and spatially resolved assays can offer amplified detection signals for multianalyte immunoassays. Multilabel methods need several labels, such as radioisotopes (15 ), fluorescence dyes (16 ), enzymes (17,18 ), metal ions (12,14,19 ), or quantum dots (20,21 ), which limits their application. Spatially resolved array assays with a single label can perform simultaneous detection of analytes by both optical (22)(23)(24) and electrochemical (25 ) responses.…”
mentioning
confidence: 99%
“…In particular, IAC should be tested using rFabs encapsulated in a sol-gel glass (SGG) matrix. [74][75][76][77][78] When antibodies to additional PAHs become available, they should be tested in the newer, micro-scaled multiplex immunoassay [79][80][81] and microarray ELISA 82 formats.…”
Section: To What Extent Does the New Scientific Knowledge Bridge The mentioning
confidence: 99%